Atlas Trials

FIGO Stage IIIA2 Ovarian Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch FIGO Stage IIIA2 Ovarian Cancer

RecordFirmDate
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02713386)NRG Oncology2016-11-14
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT01097746)M.D. Anderson Cancer Center2010-04-14

Track FIGO Stage IIIA2 Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.